Lv31
250 积分 2022-02-10 加入
P4.07D.01 Neoadjuvant Osimertinib Followed by Radiation And/or Surgery in Stage III EGFR-Mutant NSCLC: An Open-Label, Single-Arm, Phase 2 Study
3小时前
求助中
P4.07D.01 Neoadjuvant Osimertinib Followed by Radiation And/or Surgery in Stage III EGFR-Mutant NSCLC: An Open-Label, Single-Arm, Phase 2 Study
3小时前
求助中
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study
3小时前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
3小时前
待确认
Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
2个月前
已完结
Safety and Efficacy of RT002, an Injectable Botulinum Toxin Type A, for Treating Glabellar Lines
4个月前
已完结
Daxxify: Recommendations for Treatment
4个月前
已完结
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
4个月前
已关闭
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
5个月前
已完结
Daxxify: Recommendations for Treatment
5个月前
已完结
皖公网安备34019202002308
